Showing 38,061 - 38,080 results of 74,162 for search '(( 50 ((ms decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (mean decrease)) ))', query time: 1.07s Refine Results
  1. 38061

    Table_1_Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients.xlsx by Dafa Ding (6548732)

    Published 2022
    “…We observed a statistically significant decrease in HbA1c% (from 7.565 ± 0.148 to 7.190 ± 0.210, p<0.01), blood glucose (from 8.483 ± 0.497 to 7.286 ± 0.454 mmol/L, p<0.01), and uric acid (from 309.4 ± 21.5 to 259.1 ± 15.8 µmol/L, p<0.01) while a significant increase in postprandial C-peptide (from 4.503 ± 0.600 to 5.471 ± 0.728 ng/ml, p<0.01) at 12 weeks after FMT. …”
  2. 38062

    Image1_Genetic interactions of schizophrenia using gene-based statistical epistasis exclusively identify nervous system-related pathways and key hub genes.pdf by Sathish Periyasamy (478304)

    Published 2024
    “…Using the odds ratio (OR), we identified the GIs that increase or decrease the risk of a disease phenotype. …”
  3. 38063

    Table_3_Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients.docx by Dafa Ding (6548732)

    Published 2022
    “…We observed a statistically significant decrease in HbA1c% (from 7.565 ± 0.148 to 7.190 ± 0.210, p<0.01), blood glucose (from 8.483 ± 0.497 to 7.286 ± 0.454 mmol/L, p<0.01), and uric acid (from 309.4 ± 21.5 to 259.1 ± 15.8 µmol/L, p<0.01) while a significant increase in postprandial C-peptide (from 4.503 ± 0.600 to 5.471 ± 0.728 ng/ml, p<0.01) at 12 weeks after FMT. …”
  4. 38064

    Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study by Arto A. Palmu (703832)

    Published 2017
    “…<div><p>Background</p><p>The ten-valent pneumococcal conjugate vaccine (PCV10) was introduced into the Finnish National Vaccination Program (NVP) in September 2010 using a 2+1 schedule (3, 5, 12 months). We estimated the direct and indirect effects of PCV10 on pneumonia among children to evaluate the public health impact of the vaccine.…”
  5. 38065

    Image_1_Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients.pdf by Dafa Ding (6548732)

    Published 2022
    “…We observed a statistically significant decrease in HbA1c% (from 7.565 ± 0.148 to 7.190 ± 0.210, p<0.01), blood glucose (from 8.483 ± 0.497 to 7.286 ± 0.454 mmol/L, p<0.01), and uric acid (from 309.4 ± 21.5 to 259.1 ± 15.8 µmol/L, p<0.01) while a significant increase in postprandial C-peptide (from 4.503 ± 0.600 to 5.471 ± 0.728 ng/ml, p<0.01) at 12 weeks after FMT. …”
  6. 38066

    Table_2_Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients.xlsx by Dafa Ding (6548732)

    Published 2022
    “…We observed a statistically significant decrease in HbA1c% (from 7.565 ± 0.148 to 7.190 ± 0.210, p<0.01), blood glucose (from 8.483 ± 0.497 to 7.286 ± 0.454 mmol/L, p<0.01), and uric acid (from 309.4 ± 21.5 to 259.1 ± 15.8 µmol/L, p<0.01) while a significant increase in postprandial C-peptide (from 4.503 ± 0.600 to 5.471 ± 0.728 ng/ml, p<0.01) at 12 weeks after FMT. …”
  7. 38067

    Table_1_Extrapolating Antibiotic Sales to Number of Treated Animals: Treatments in Pigs and Calves in Switzerland, 2011–2015.DOCX by Rosa Stebler (7408247)

    Published 2019
    “…Using the number of slaughtered animals for that year as denominator, we calculated a treatment intensity of 2.15 therapies per pig and 5.96 per calf. …”
  8. 38068

    Transfection of catalytically active BPLF1 inhibits activation of the DDR and DNA repair in etoposide treated HeLa cells. by Jinlin Li (2267896)

    Published 2021
    “…Mean ± SE of two or three independent experiments where a minimum of 50 BPLF1 positive and 50 BPLF1 negative cells was scored in each condition.…”
  9. 38069
  10. 38070
  11. 38071
  12. 38072
  13. 38073
  14. 38074

    Selective VCP inhibition induces significant cell cycle arrest in G2/M phase. by Kyla Walworth (3150936)

    Published 2016
    “…<p>(A) Following a 24-hour treatment period with control-PBS, NMS-873/DBeQ (50μM, positive-control), dendrimer (DDN) or dendrimer-encapsulated DBeQ (DDN<sup>DBeQ</sup>, 50 μM), cells were fixed with ice-cold 70%-ethanol followed by staining with propidium iodide (10μg/mL) for 1 hour. …”
  15. 38075
  16. 38076
  17. 38077
  18. 38078

    Sertoli cell-specific ablation in adulthood. by Diane Rebourcet (153547)

    Published 2014
    “…<p>(A) Amh-Cre;iDTR model. (B) DTR expression is restricted to Sertoli cells (scale bar: 50 µm). …”
  19. 38079
  20. 38080

    Down syndrome: Prevalence and distribution of congenital heart disease in Brazil by Beatriz Elizabeth Bagatin Veleda Bermudez (12799493)

    Published 2022
    “…DESIGN AND SETTING : Cross-sectional study conducted in a referral center. METHODS : Data were retrospectively gathered from the medical files of 1,207 patients with Down syndrome, among whom 604 (50.0%) had been diagnosed with congenital heart disease. …”